|
![]() |
|
|
XANAX_XR: profile and news
Pfizer First-Quarter 2006 Financial Results Reflect Operating and ... Apr 19, 2006 Other information Indication For the treatment or management of panic disorder, with or without agoraphobia Pharmacology Alprazolam, a benzodiazepine, is used to treat panic disorder and anxiety disorder. Unlike chlordiazepoxide, clorazepate, and prazepam, alprazolam has a shorter half-life and yields metabolites with minimal activity. Like other triazolo benzodiazepines such as triazolam, alprazolam may have significant drug interactions involving the hepatic cytochrome P-450 3A4 isoenzyme. Mechanism Of Action Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing membrane that prevents further excitation of the cell. Drug Category Anti-anxiety Agents; Hypnotics and Sedatives; Benzodiazepines; GABA Modulators; Brand Names/Synonyms Alplax; Alprazolam; Alpronax; Bestrol; Cassadan; Constan; D 65MT; Esparon; Frontal; Intensol; Niravam; TUS-1; Tafil; Trankimazin; Tranquinal; Xanax; Xanax Xr; Xanor Dosage Forms TABLET Absorption Following oral administration Benzodiazepines are well absorbed from the gastrointestinal tract, usually within 1 to 2 hours. Following intramuscular administration _ Lorazepam absorption is rapid and complete, whereas chlordiazepoxide and diazepam absorption may be slow and erratic, depending upon the site of administration . When diazepam is injected into the deltoid muscle, absorption is usually rapid and complete . Following rectal administration _ Absorption of diazepam rectal solution and rectal gel is rapid. Interactions -->Interactions for Alprazolam: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression. The steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day. The clinical significance of these changes is unknown. Drugs That Inhibit Alprazolam Metabolism Via Cytochrome P450 3A: The initial step in alprazolam metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A). Drugs which inhibit this metabolic pathway may have a profound effect on the clearance of alprazolam . Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam):
Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice. Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine. Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine. Caution is recommended during the coadministration of any of these with alprazolam. Chemical IUPAC Name 8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Chemical Formula C17H13ClN4 Half Life 6.3-26.9 hours (average = 11.2 hrs) Drug Type Approved Drug # Accession No APRD00280 CAS Registry Number 28981-97-7 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |